Cancer Biology - MRes

Research Methods and Bioethics (20 cp) - This module encourages you to think beyond your own subject, and interact accordingly. You'll gain a solid foundation in literature review, research design and planning, data analysis and a poster presentation by focusing your studies on a related ethical issue. Ethical issues in research will also be explored, as you discover when and how to obtain ethical clearance in accordance with ethical governance at NTU.

Research Project (120 cp) - In consultation with a supervisor at NTU, you'll select a research topic comprising an original, defined research question (or series of such questions), and develop a written research proposal for the Project. You'll then present this proposal as part of the Research Methods and Bioethics module.

Working individually with the guidance of supervisors, you'll design your experiments and computer-based approaches to address the research questions. A diary-style record of protocols or methods will be used to generate entries for your skills portfolio.

You'll communicate your findings through a written thesis, and a poster presentation. For the MRes course, an interim written report and oral presentation will be assessed after six to eight months of work, in order to review your progress.

Cell Culture and Antibody Technology (20 cp) - You'll explore the scientific basis of cell culture and antibody technologies, and assess how they're used to solve problems in biotechnology, molecular biosciences, and biomedical sciences. You'll look at the relationship between cell and antibody technologies, as well as other technologies, particularly recombinant DNA technology and how these may develop in the future.

Biology of Disease (20 cp) - You’ll gain an understanding of the pathogenesis of cancer, cardiovascular disease, diabetes and kidney fibrosis. The lectures and seminars examine cancer aetiology, the genotypic and phenotypic properties associated with tumour progression, metastasis, and the current approaches to cancer gene therapy and immunotherapy.